Read + Share
Amedeo Smart
Independent Medical Education
Vangeel L, Chiu W, De Jonghe S, Maes P, et al. Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern. Antiviral Res 2022 Jan 24:105252. doi: 10.1016/j.antiviral.2022.105252.PMID: 35085683
Email
LinkedIn
Facebook
Twitter
Privacy Policy